By directly targeting the heart, we aim to affect key biological processes in the pathology of cardiac diseases. By using our unique human cardiac in vitro models for target and compound validation, we create a human relevant drug pipeline. Our mission: Bring novel cardiac therapies to patients more efficiently by leveraging our human cardiac in vitro models.